AI assistant
MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2016
Aug 8, 2016
65285_rns_2016-08-08_5912820a-ac8d-4737-9753-14c5033d66f2.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
ASX Announcement
9 August 2016
==> picture [610 x 89] intentionally omitted <==
Mach7 Signs UK Distribution Agreement with Leading Healthcare I.T. Solutions Provider
Highlights:
-
Leading UK healthcare solutions provider Soliton IT appointed as distributor
-
Soliton IT has large existing installation base of 100+ healthcare sites in UK
-
Significant market opportunity with strong growth in UK healthcare spending
Melbourne, Australia; 9 August 2016: Mach7 Technologies Limited ( Mach7 or the Company ) (ASX: M7T ), a global provider of enterprise imaging solutions, today announced it has entered into a Distribution Agreement ( Agreement ) with Soliton IT Limited ( Soliton ) for the distribution of Mach7 Technologies™ enterprise imaging solutions throughout the United Kingdom ( Territory ).
The World Bank has reported that healthcare expenditure in the United Kingdom has risen consistently year-on-year and now accounts for 9.1% of GDP. The United Kingdom is seen as a well-developed and highly prospective market for the Company’s software offering. Since the release of Mach7 Enterprise Imaging Platform in 2012, the Company has already secured a number of UK-based customers, including London Imaging and HCA International.
Under the terms of the Agreement, Soliton has been appointed as a non-exclusive distributor to promote, market and distribute the entire Mach7 suite of solutions, including their flagship product, Mach7 Enterprise Imaging Platform. Additionally, Soliton will provide user training and customer support throughout the Territory. Mach7 selected Soliton because of their deep understanding of the health informatics market, their extensive installation base and leading market share in the Radiology Information Systems (RIS) market in the UK. Currently Soliton manages and supports software installations in more 100 healthcare sites in the UK. Soliton is also an approved supplier under the UK NHS Framework.
Bob Watson, managing director of Soliton IT, says “we are impressed with Mach7’s product line, their innovative approach and dedication to their customers which mirrors our values. We look forward to working with Mach7 to bring their award-winning technology to the UK.”
==> picture [610 x 123] intentionally omitted <==
ASX Announcement
9 August 2016
==> picture [610 x 89] intentionally omitted <==
“The UK is a thriving market for modern enterprise imaging and VNA solutions,” said Reuven Soraya, senior vice president, international sales at Mach7. “We look forward to leveraging Soliton’s expertise and strong and growing presence in UK healthcare informatics to advance patient care delivery across the UK.”
-ENDS
About Soliton IT:
Soliton IT is a healthcare-targeted solutions company based in UK and Australia. Established in 2004, Soliton IT designs, supplies and installs Radiology Information Systems (RIS), Workflow Management programs and Voice Recognition systems into UK NHS Trusts, clinics, teaching centres and private hospitals. With particular expertise in multi-user/inter-site environments, data migration and system integration, Soliton IT is committed to providing healthcare sites with efficient, customisable solutions and in the UK it has been appointed as an approved supplier on the National RIS/PACS/VR Framework. Soliton IT has radiology software installations in more than 100 leading healthcare centres across the United Kingdom. Visit www.solitionit.com
About Mach7 Technologies:
Mach7 Technologies (ASX:M7T) develops innovative enterprise imaging IT solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Mach7’s award-winning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their best-of-breed clinical ecosystems. Mach7’s sophisticated workflow tools, advanced clinical viewing and optimised vendor neutral archiving solutions unlock silos of legacy systems empowering healthcare providers to own, access and share patient data without boundaries. Visit www.mach7t.com
Mach7’s wholly-owned subsidiary, 3D Medical Pty Ltd, provides medical specific 3D printing and is an exclusive distributor of various synergistic technologies including holographic projection. 3D Medical’s innovative products leverage data already captured by conventional imaging modalities and apply it in more meaningful ways to deliver improved economic and patient outcomes. Visit http://3dmedical.com.au
Contacts:
Albert Liong CEO +1 650 743 0167 (U.S.) [email protected]
Jenni Pilcher CEO Australia, CFO +61 3 9646 2222 (Australia) [email protected]
Julia Vaughn Investor Relations (U.S.) +1 802 768 0143 (U.S.) [email protected]
==> picture [610 x 123] intentionally omitted <==